Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses
Research and development	$ 16,157	$ 10,298
General and administrative	5,645	4,774
Total operating expenses	21,802	15,072
Loss from operations	(21,802)	(15,072)
Interest income	624	1,386
Other expense, net	(63)	(42)
Total other income, net	561	1,344
Net loss and comprehensive loss	$ (21,241)	$ (13,728)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (1.41)	$ (1.03)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) (in Dollars per share)	$ (1.41)	$ (1.03)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)	15,022,122	13,334,900
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares) (in Shares)	15,022,122	13,334,900